MiR‐146a‐5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor‐alpha inhibitor adalimumab.
- Resource Type
- Article
- Source
British Journal of Dermatology . Sep2018, Vol. 179 Issue 3, p787-789. 3p.- Subject
- *
MICRORNA
*PSORIASIS
*ADALIMUMAB
*BLOOD plasma
*PATIENTS
*THERAPEUTICS - Language
- ISSN
- 0007-0963